Metronidazole represents the gold standard in nitroimidazole antibiotics, specifically targeting anaerobic bacteria and protozoa by disrupting DNA synthesis through reactive intermediates.
As a leading supplier, Jiangxi Serum Pharma Industries Co., Ltd. integrates advanced Chinese manufacturing with global GMP standards to ensure API stability and bioavailability.
Compliance with BP/USP/EP standards is not just a requirement; it is our baseline for ensuring patient safety across diverse therapeutic landscapes.
Metronidazole is a synthetic nitroimidazole derivative with potent antibacterial and antiprotozoal activity. Since its discovery, it has remained a cornerstone in the treatment of various infections. At Jiangxi Serum Pharma Industries Co., Ltd., we recognize that the efficacy of Metronidazole tablets depends significantly on the purity of the Active Pharmaceutical Ingredient (API) and the precision of the formulation process.
The global Metronidazole market is projected to witness steady growth due to the rising prevalence of gastrointestinal infections and surgical site prophylaxis needs. China and India currently dominate the supply chain, accounting for over 60% of the world's Metronidazole API production. The shift toward vertically integrated manufacturing—where companies like Jiangxi Serum Pharma manage everything from intermediate sourcing to finished dosage forms—has redefined cost-efficiency and supply chain resilience.
Current trends show an increasing reliance on Metronidazole as part of triple or quadruple therapy regimens for H. pylori eradication. Furthermore, there is a growing industrial focus on "Smart Drug Delivery" systems, including sustained-release Metronidazole tablets that minimize gastrointestinal side effects while maintaining therapeutic plasma concentrations for longer durations.
Established
Global Clients
Annual Sales
Trusted Suppliers
In regions such as Southeast Asia and Sub-Saharan Africa, Metronidazole tablets are vital in managing amoebic liver abscesses and giardiasis, where water hygiene remains a challenge.
In Western medical facilities, the focus is on anaerobic coverage during colorectal surgeries, ensuring rapid recovery and preventing polymicrobial infections.
Beyond human health, Metronidazole is extensively used in the treatment of giardia in livestock and pet care, showcasing its versatility across biological systems.
The next decade of Metronidazole application will be defined by three pillars: Bio-Fermentation, Nano-formulation, and Personalized Dosing. Serum Pharma is already exploring Co-Crystallization techniques to enhance the solubility of nitroimidazole compounds, which historically have had challenges with taste masking and pediatric compliance.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts. Our mission is to bring premium products back to health at affordable prices.
We provide more than just products; we provide comprehensive pharmaceutical solutions. From Regulatory Affairs Support (DMF, Dossier preparation) to Custom Manufacturing (CMO/CDMO), Jiangxi Serum Pharma acts as a bridge between high-quality Chinese production and global healthcare needs. Our nutritional ingredients cover categories like plant oils, proteins, and probiotics, deriving purity from nature to maintain body balance.
Metronidazole is primarily used for bacterial vaginosis, trichomoniasis, amebiasis, and anaerobic bacterial infections. It is also a key component in H. pylori eradication therapy.
We work with GMP-certified manufacturing sites and conduct rigorous internal audits. Every batch is tested for potency, purity, and microbial limits according to international pharmacopeia standards (USP/BP).
Pre-Mix services allow pharmaceutical manufacturers to receive ready-to-use ingredient blends, reducing production time, minimizing cross-contamination risks, and ensuring uniform distribution of active ingredients.
Patients are strictly advised to avoid alcohol during treatment and for at least 48 hours after, due to a disulfiram-like reaction which causes nausea, vomiting, and flushing.
